Altamira Therapeutics (CYTO) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Altamira Therapeutics Ltd. has issued a pre-funded common share purchase warrant, enabling holders to subscribe and purchase common shares from the company from September 19, 2024, until the warrant’s full exercise. The purchase price per share is predetermined as described in the Warrant, with the exercise price largely pre-funded to the company, requiring only a nominal additional payment upon exercise.
For further insights into CYTO stock, check out TipRanks’ Stock Analysis page.